Skip to content

CLBP Single-Arm Long-Term Follow-up Study

A Prospective, Open-Label, Single-Arm Study of Intraosseous Basivertebral Nerve Ablation for the Treatment of Chronic Low Back Pain Long-term Follow Up

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05207813
Enrollment
42
Registered
2022-01-26
Start date
2022-02-16
Completion date
2024-02-01
Last updated
2025-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Low Back Pain

Keywords

Vertebrogenic chronic low back pain, Intraosseous basivertebral nerve ablation, Low back pain, Axial low back pain

Brief summary

This is a prospective, noninterventional, observational post market data collection of long-term effectiveness and satisfaction outcomes for A Prospective, Open-Label, Single-Arm Study of Intraosseous Basivertebral Nerve Ablation for the Treatment of Chronic Low Back Pain (CLBP Single-Arm Study) population at three (3), four (4), and five (5) years post Intracept Procedure. The working hypothesis is that data collected in this study will demonstrate safety, efficacy, durability and reproducibility of BVN ablation treatment outcomes out to 3, 4, and 5-years post-procedure.

Detailed description

Patients were originally enrolled under NCT03266107 and followed through 12-months post Intracept Procedure. This study approached patients from NCT03266107 to collect additional long-term effectiveness and satisfaction outcomes at three (3), four (4), and five (5) years post Intracept Procedure.

Interventions

Intraosseous Basivertebral Nerve (BVN) Ablation

Sponsors

Boston Scientific Corporation
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
25 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

\- Patient received the Intracept procedure while participating in A Prospective, Open-Label, Single-Arm Study of Intraosseous Basivertebral Nerve Ablation for the Treatment of Chronic Low Back Pain (CLBP Single-Arm Long-Term Study)

Exclusion criteria

\- None

Design outcomes

Primary

MeasureTime frameDescription
Mean Change in ODI From Baseline to 5 Years Post Intracept ProcedureDifference between baseline and 5-year post treatment measurements. Patients originally enrolled under NCT03266107. Baseline information for this analysis is from NCT03266107. 5-years post Intracept Procedure data collected through this NCT record/study.The Oswestry Disability Index (ODI) is a validated questionnaire of pain-related disability with total score on a scale of 0 (no disability) to 100 (complete disability). Categories for ODI total score are 0-20 (minimal disability), 21-40 (moderate disability), 41-60 (severe disability), 61-80 (crippling back pain), and 81-100 (bed-bound or exaggerating). The published minimally clinically important difference for change in ODI is 10 points.

Secondary

MeasureTime frameDescription
Mean Change in Oswestry Disability Index (ODI) From Baseline to 3 Years Post Intracept ProcedureDifference between baseline and 3-year post treatment measurements. Patients originally enrolled under NCT03266107. Baseline information for this analysis is from NCT03266107. 3-years post Intracept Procedure data collected through this NCT record/study.The Oswestry Disability Index (ODI) is a validated questionnaire of pain-related disability with total score on a scale of 0 (no disability) to 100 (complete disability). Categories for ODI total score are 0-20 (minimal disability), 21-40 (moderate disability), 41-60 (severe disability), 61-80 (crippling back pain), and 81-100 (bed-bound or exaggerating). The published minimally clinically important difference for change in ODI is 10 points.
Mean Change in ODI From Baseline to 4 Years Post Intracept ProcedureDifference between baseline and 4-year post treatment measurements. Patients originally enrolled under NCT03266107. Baseline information for this analysis is from NCT03266107. 4-years post Intracept Procedure data collected through this NCT record/study.The Oswestry Disability Index (ODI) is a validated questionnaire of pain-related disability with total score on a scale of 0 (no disability) to 100 (complete disability). Categories for ODI total score are 0-20 (minimal disability), 21-40 (moderate disability), 41-60 (severe disability), 61-80 (crippling back pain), and 81-100 (bed-bound or exaggerating). The published minimally clinically important difference for change in ODI is 10 points.

Countries

United States

Participant flow

Participants by arm

ArmCount
Basivertebral Nerve Ablation Treatment
Patient-reported outcomes at three (3) follow-up visits for previously treated participants from the CLBP Single-Arm study. Intracept Procedure: Intraosseous Basivertebral Nerve (BVN) Ablation
40
Total40

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up2

Baseline characteristics

CharacteristicBasivertebral Nerve Ablation Treatment
Age, Continuous45.75 years
STANDARD_DEVIATION 8.53
Oswestry Disability Index (ODI)47.05 score on a scale
STANDARD_DEVIATION 10.17
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United States
40 participants
Sex: Female, Male
Female
23 Participants
Sex: Female, Male
Male
17 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 40
other
Total, other adverse events
0 / 40
serious
Total, serious adverse events
0 / 40

Outcome results

Primary

Mean Change in ODI From Baseline to 5 Years Post Intracept Procedure

The Oswestry Disability Index (ODI) is a validated questionnaire of pain-related disability with total score on a scale of 0 (no disability) to 100 (complete disability). Categories for ODI total score are 0-20 (minimal disability), 21-40 (moderate disability), 41-60 (severe disability), 61-80 (crippling back pain), and 81-100 (bed-bound or exaggerating). The published minimally clinically important difference for change in ODI is 10 points.

Time frame: Difference between baseline and 5-year post treatment measurements. Patients originally enrolled under NCT03266107. Baseline information for this analysis is from NCT03266107. 5-years post Intracept Procedure data collected through this NCT record/study.

Population: Patients who completed all long-term follow-up visits (3-, 4-, 5-year follow-up visit).

ArmMeasureValue (MEAN)Dispersion
Basivertebral Nerve Ablation TreatmentMean Change in ODI From Baseline to 5 Years Post Intracept Procedure34.63 units on a scaleStandard Deviation 10.12
Secondary

Mean Change in ODI From Baseline to 4 Years Post Intracept Procedure

The Oswestry Disability Index (ODI) is a validated questionnaire of pain-related disability with total score on a scale of 0 (no disability) to 100 (complete disability). Categories for ODI total score are 0-20 (minimal disability), 21-40 (moderate disability), 41-60 (severe disability), 61-80 (crippling back pain), and 81-100 (bed-bound or exaggerating). The published minimally clinically important difference for change in ODI is 10 points.

Time frame: Difference between baseline and 4-year post treatment measurements. Patients originally enrolled under NCT03266107. Baseline information for this analysis is from NCT03266107. 4-years post Intracept Procedure data collected through this NCT record/study.

Population: Patients who completed all long-term follow-up visits (3-, 4-, 5-year follow-up visit).

ArmMeasureValue (MEAN)Dispersion
Basivertebral Nerve Ablation TreatmentMean Change in ODI From Baseline to 4 Years Post Intracept Procedure34.50 units on a scaleStandard Deviation 12.26
Secondary

Mean Change in Oswestry Disability Index (ODI) From Baseline to 3 Years Post Intracept Procedure

The Oswestry Disability Index (ODI) is a validated questionnaire of pain-related disability with total score on a scale of 0 (no disability) to 100 (complete disability). Categories for ODI total score are 0-20 (minimal disability), 21-40 (moderate disability), 41-60 (severe disability), 61-80 (crippling back pain), and 81-100 (bed-bound or exaggerating). The published minimally clinically important difference for change in ODI is 10 points.

Time frame: Difference between baseline and 3-year post treatment measurements. Patients originally enrolled under NCT03266107. Baseline information for this analysis is from NCT03266107. 3-years post Intracept Procedure data collected through this NCT record/study.

Population: Patients who completed all long-term follow-up visits (3-, 4-, 5-year follow-up visit).

ArmMeasureValue (MEAN)Dispersion
Basivertebral Nerve Ablation TreatmentMean Change in Oswestry Disability Index (ODI) From Baseline to 3 Years Post Intracept Procedure33.25 units on a scaleStandard Deviation 10.75

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026